Thursday, July 17, 2014 3:47:17 PM
There are very few I'll hold long term at this point. I've traded out of quite a few favourites to sit and watch and buy back in lower. Hard to time though. Walked away with profit too early on a few. But, overall, it's paying off, even with one really bad one. The key is to have more good than bad trades. It's all a matter of probabilities.
In Reply to 'I Need Help'
Been a very interesting day.
NNVC showing lots of resilience.
Accumulation and distribution. Great activity.
Volume for NNVC (no news) is excellent.
I got in at $3.98, so lots of cushion for me. I am going to hold and see what happens with all this volume. Accumulators are not done. Sellers are more likely to run out first.
Shorts for this rally should be out. If not, oh well. But, new shorts may be coming in.
Several resistance levels coming up. We apparently are hitting one today.
But, accumulation is encouraging me. PPS got hit several times on low volume and has come back on higher volume. Bought additional shares on one dip this morning for a fairly quick 5%.
I don't know if this accumulation is news driven, could be players taking positions. Word about NNVC may be getting out there.
Just a reminder, NNVC is not the center of the investing universe. Keep open to other possibilities, along with NNVC. My plunge into volatility today netted me 14%, and am in and out.
Long shot, but still enough time for NNVC to end higher. If so, it would be hugh technical.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM